Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, an…
Medical - Instruments & Supplies
US, Franklin Lakes [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
---|---|---|---|---|---|---|---|
$16,201
d
cs
10% Holder
|
01/07/25 |
S
|
788 x $235.00 = $185,180.00 |
Footnotes
#1 Represents shares withheld for payment of withholding taxes in connection with the distribution of shares pursuant to the Becton, Dickinson and Company deferred compensation plan.
|
|||
$6,241
d
cs
10% Holder
|
01/03/25 |
F
|
44 x $0 = $0 |
Footnotes
#1 Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards.
|
|||
$6,141
d
cs
10% Holder
|
12/19/24 |
S
|
2,838 x $223.33 = $633,810.54 |
Footnotes
|
|||
$14,217
d
cs
10% Holder
|
12/09/24 |
S
|
638 x $219.03 = $139,741.14 |
Footnotes
#1 The reported sale price reflects the weighted average sale price for two transactions. The actual sales prices for the transactions were $220.88 and $221.02. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission upon request.
|
|||
$24,345
d
cs
10% Holder
|
12/06/24 |
S
|
4,483 x $221.01 = $990,787.83 |
Footnotes
#1 The reported sale price reflects the weighted average sale price for two transactions. The actual sales prices for the transactions were $220.88 and $221.02. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission upon request.
|
Statistics
Sample Size: 76 Transactions
Sale (S)
20,144 Shares
19.74%
Buy (P)
0 Shares
0.00%
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Brown William M Director
- Burzik Catherine M Director
- Byington Carrie L Director
- Byrd Richard EVP & President Interventional
- Delorefice Christopher EVP & Chief Financial Officer
- Eckert R Andrew Director
- Ezell Antoine C EVP, President Americas & CMO
- Feld Michael EVP & President, Life Sciences
- Fraser Claire Director
- Garrison Michael David EVP & President, Medical
- Goette Roland EVP and President, EMEA
- Henderson Jeffrey William Director
- Jones Christopher Ian Montague Director
- Mocherla Pavan Kumar EVP & President Greater Asia
- Neal Shana Carol EVP and Chief People Officer
- Polen Thomas E Jr Chairman, CEO and President
- Quinn Michelle EVP and General Counsel
- Ring Timothy M Director
- Scott Bertram L Director
- Shan David EVP and Chief ISC Officer
- Spoerel Thomas J SVPController & Chief Acct Off
- Waldstreicher Joanne Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Brown William M Director
- Burzik Catherine M Director
- Byington Carrie L Director
- Byrd Richard EVP & President Interventional
- Delorefice Christopher EVP & Chief Financial Officer
- Eckert R Andrew Director
- Ezell Antoine C EVP, President Americas & CMO
- Feld Michael EVP & President, Life Sciences
- Fraser Claire Director
- Garrison Michael David EVP & President, Medical
- Goette Roland EVP and President, EMEA
- Henderson Jeffrey William Director
- Jones Christopher Ian Montague Director
- Mocherla Pavan Kumar EVP & President Greater Asia
- Neal Shana Carol EVP and Chief People Officer
- Polen Thomas E Jr Chairman, CEO and President
- Quinn Michelle EVP and General Counsel
- Ring Timothy M Director
- Scott Bertram L Director
- Shan David EVP and Chief ISC Officer
- Spoerel Thomas J SVPController & Chief Acct Off
- Waldstreicher Joanne Director